KyungDong Pharm Co., Ltd. launches “Heavycom Capsule,” a treatment for complex liver diseases, on February 1, 2018.
“Heavycom Capsule” is a complex liver disease treatment that combines biphenyldimethyldicarboxylate (DDB), which lowers ALT levels in liver disease patients, and ursodeoxycholic acid (UDCA), a hydrophilic bile acid, in an optimal ratio.
“Heavycomb Capsule”, which effectively improves serum ALT levels in patients with chronic hepatitis due to various causes and promotes liver cell regeneration and inhibits destruction, is expected to be helpful in the treatment of chronic hepatitis patients along with KyungDong Pharm Co., Ltd.’s Rihel Tablet (DDB 25mg).
♤ Product Information ♤
-
Product Name: Heavycom Capsule
-
Ingredient content: Biphenyldimethyldicarboxylate 12.5mg, ursodeoxycholic acid 50mg
-
Indication: chronic persistent hepatitis with persistently elevated SGPT levels
-
Dosage: Normally, adults take 1 capsule per time, orally, 3 times a day after meals.
-
Insurance price: 260 won/capsule
-
Insurance Code: 648104020
-
Packaging unit: 30 capsules, 300 capsules